{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:11:37Z","timestamp":1790057497112,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10096-019-03535-w","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T08:03:26Z","timestamp":1554797006000},"page":"1255-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-3244","authenticated-orcid":false,"given":"Stan J. F.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin P.","family":"Boeddha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Hazelzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan J.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia N.","family":"de Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"3535_CR1","doi-asserted-by":"publisher","unstructured":"De Waele JJ, Lipman J, Akova M et al (2014) Risk factors for target non-attainment during empirical treatment with beta-lactam antibiotics in critically ill patients. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-014-3403-8","DOI":"10.1007\/s00134-014-3403-8"},{"key":"3535_CR2","doi-asserted-by":"publisher","unstructured":"De Cock PA, Standing JF, Barker CI et al (2015) Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01368-15","DOI":"10.1128\/AAC.01368-15"},{"key":"3535_CR3","doi-asserted-by":"publisher","unstructured":"De Cock PA, van Dijkman SC, de Jaeger A et al (2017) Dose optimization of piperacillin\/tazobactam in critically ill children. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkx093","DOI":"10.1093\/jac\/dkx093"},{"key":"3535_CR4","doi-asserted-by":"publisher","unstructured":"Bressolle F, Gouby A, Martinez JM et al (1996) Population pharmacokinetics of amikacin in critically ill patients. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.40.7.1682","DOI":"10.1128\/AAC.40.7.1682"},{"key":"3535_CR5","doi-asserted-by":"publisher","unstructured":"B\u00e9ranger A, Oualha M, Urien S et al (2018) Population pharmacokinetic model to optimize cefotaxime dosing regimen in critically ill children. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-017-0602-9","DOI":"10.1007\/s40262-017-0602-9"},{"key":"3535_CR6","doi-asserted-by":"publisher","unstructured":"Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(14)70036-2","DOI":"10.1016\/S1473-3099(14)70036-2"},{"key":"3535_CR7","doi-asserted-by":"publisher","unstructured":"Barker CI, Standing JF, Turner MA et al (2012) Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic\/pharmacodynamic studies - and when is enough data enough? Curr Opin Infect Dis. https:\/\/doi.org\/10.1097\/QCO.0b013e328353105c","DOI":"10.1097\/QCO.0b013e328353105c"},{"key":"3535_CR8","doi-asserted-by":"publisher","unstructured":"Rosenstein NE, Perkins BA, Stephens DS et al (2001) Meningococcal disease. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJM200105033441807","DOI":"10.1056\/NEJM200105033441807"},{"key":"3535_CR9","doi-asserted-by":"publisher","unstructured":"de Kleijn ED, de Groot R, Hack CE et al (2003) Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med. https:\/\/doi.org\/10.1097\/01.CCM.0000072121.61120.D8","DOI":"10.1097\/01.CCM.0000072121.61120.D8"},{"key":"3535_CR10","doi-asserted-by":"publisher","unstructured":"Abdulla A, Bahmany S, Wijma RA et al (2017) Simultaneous determination of nine beta-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. https:\/\/doi.org\/10.1016\/j.jchromb.2017.06.014","DOI":"10.1016\/j.jchromb.2017.06.014"},{"key":"3535_CR11","doi-asserted-by":"publisher","unstructured":"Craig WA (1995) Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. https:\/\/doi.org\/10.1016\/0732-8893(95)00053-D","DOI":"10.1016\/0732-8893(95)00053-D"},{"key":"3535_CR12","doi-asserted-by":"publisher","unstructured":"McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.12.009","DOI":"10.1016\/j.ijantimicag.2007.12.009"},{"key":"3535_CR13","doi-asserted-by":"publisher","unstructured":"Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med. https:\/\/doi.org\/10.1097\/CCM.0b013e3181961bff","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"3535_CR14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2017) Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1. http:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents"},{"key":"3535_CR15","doi-asserted-by":"publisher","unstructured":"Hartman ME, Linde-Zwirble WT, Angus DC (2013) Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med. https:\/\/doi.org\/10.1097\/PCC.0b013e3182917fad","DOI":"10.1097\/PCC.0b013e3182917fad"},{"key":"3535_CR16","doi-asserted-by":"publisher","unstructured":"Luthy R, Munch R, Blaser J et al (1979) Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.16.2.127","DOI":"10.1128\/AAC.16.2.127"},{"key":"3535_CR17","doi-asserted-by":"publisher","unstructured":"Roberts JA, Webb S, Paterson D et al (2009) A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a0054d","DOI":"10.1097\/CCM.0b013e3181a0054d"},{"key":"3535_CR18","doi-asserted-by":"publisher","unstructured":"Falagas ME, Tansarli GS, Ikawa K et al (2013) Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin\/tazobactam: a systematic review and meta-analysis. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/cis857","DOI":"10.1093\/cid\/cis857"},{"key":"3535_CR19","doi-asserted-by":"publisher","unstructured":"Woksepp H, Hallgren A, Borgstrom S et al (2016) High target attainment for beta-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-016-2832-4","DOI":"10.1007\/s10096-016-2832-4"},{"issue":"3","key":"3535_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JCM.21.3.366-370.1985","volume":"21","author":"DJ Nickolai","year":"1985","unstructured":"Nickolai DJ, Lammel CJ, Byford BA et al (1985) Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. J Clin Microbiol 21(3):366\u2013370","journal-title":"J Clin Microbiol"},{"key":"3535_CR21","doi-asserted-by":"publisher","unstructured":"Abhilash B, Tripathi CD, Gogia AR et al (2016) Variability in plasma concentration of cefotaxime in critically ill patients in an Intensive Care Unit of India and its pharmacodynamic outcome: a nonrandomized, prospective, open-label, analytical study. J Pharmacol Pharmacother. https:\/\/doi.org\/10.4103\/0976-500X.179356","DOI":"10.4103\/0976-500X.179356"},{"key":"3535_CR22","doi-asserted-by":"publisher","unstructured":"Jones RN (1989) A review of cephalosporin metabolism: a lesson to be learned for future chemotherapy. Diagn Microbiol Infect Dis. https:\/\/doi.org\/10.1016\/0732-8893(89)90042-4","DOI":"10.1016\/0732-8893(89)90042-4"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03535-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03535-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03535-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T20:30:56Z","timestamp":1607200256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03535-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03535-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"assertion":[{"value":"2 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained for the original study. No additional approval obtained for secondary analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Parents or legal representatives of all participants signed informed consent for the original trial with consent for additional analyses.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}